首页> RMD open> Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA.

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA.

导出 LinkOut

翻译打印收藏纠错

第一作者： Meghna,Jani

第一单位： Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

作者： Meghna,Jani ^[1] ; William G,Dixon ^[1] ; Lianne,Kersley-Fleet ^[2] ; Ian N,Bruce ^[1] ; Hector,Chinoy ^[3] ; Anne,Barton ^[3] ; Mark,Lunt ^[2] ; Kath,Watson ^[2] ; BSRBR-RA* ^[1] ; BSRBR-RA Control Centre Consortium* ^[1] ; Deborah P,Symmons ; Kimme L,Hyrich

作者单位： Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. ^[1] Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. ^[2] Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust and University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. ^[3]

关键词 Anti-TNF DMARDs (biologic)DMARDs (synthetic)Epidemiology Rheumatoid Arthritis

DOI 10.1136/rmdopen-2016-000314

PMID 28123776

发布时间 2025-05-30

基金项目

G1000417/MRC_/Medical Research Council/United Kingdom

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览48

RMD open

2017年3卷1期

e000314页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览48

RMD open

2017年3卷1期

e000314页

检索历史清除

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA.

RMD open

相似文献

同项目论文

RMD open

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA.

RMD open

相似文献

同项目论文

RMD open

相关期刊

检索历史清除